Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

1,3,5-Triazine-azole Hybrids and their Anticancer Activity
Hua Guo, Quanping Diao
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 16, pp. 1481-1492
Closed Access | Times Cited: 25

Showing 25 citing articles:

New Benzimidazole-, 1,2,4-Triazole-, and 1,3,5-Triazine-Based Derivatives as Potential EGFRWT and EGFRT790M Inhibitors: Microwave-Assisted Synthesis, Anticancer Evaluation, and Molecular Docking Study
Heba E. Hashem, Abd El‐Galil E. Amr, Eman S. Nossier, et al.
ACS Omega (2022) Vol. 7, Iss. 8, pp. 7155-7171
Open Access | Times Cited: 55
Recent Advancements and Developments in the Biological Importance of 1,3,5‐Triazines
Bhagyashri Rathod, Swati Pawar, Sachin Puri, et al.
ChemistrySelect (2024) Vol. 9, Iss. 12
Closed Access | Times Cited: 3
Anticancer potential of cardiac glycosides and steroid-azole hybrids
Yani Hou, Congshan Shang, Tingting Meng, et al.
Steroids (2021) Vol. 171, pp. 108852-108852
Closed Access | Times Cited: 22
Design and organocatalytic synthesis of spirooxindole–cyclopentene–isoxazole hybrids as novel MDM2–p53 inhibitors
Xin Xie, Shan-Shan Xiong, Xiang Li, et al.
Organic Chemistry Frontiers (2021) Vol. 8, Iss. 8, pp. 1836-1843
Closed Access | Times Cited: 17
Recent updates on 1,2,3‐, 1,2,4‐, and 1,3,5‐triazine hybrids (2017–present): The anticancer activity, structure–activity relationships, and mechanisms of action
Gaoli Dong, Yingchun Jiang, Feng Zhang, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 3
Closed Access | Times Cited: 12
5-Aryl-1-Arylideneamino-1H-Imidazole-2(3H)-Thiones: Synthesis and In Vitro Anticancer Evaluation
Ali H. Abu Almaaty, Eslam E. M. Toson, Elsherbiny H. Elsayed, et al.
Molecules (2021) Vol. 26, Iss. 6, pp. 1706-1706
Open Access | Times Cited: 13
Synthesis and In vitro Study of Cytotoxic Activity of New Tetrazole-Containing 2,4-Diamino-1,3,5-triazine Derivatives
Olga V. Mikolaichuk, A. V. Protas, E. A. Popova, et al.
Russian Journal of General Chemistry (2022) Vol. 92, Iss. 9, pp. 1621-1628
Closed Access | Times Cited: 9
A new tetrazole-containing 2-amino-4,6-di(aziridin-1-yl)-1,3,5-triazine derivative: synthesis, interaction with DNA, and antitumor activity
Olga V. Mikolaichuk, Vladimir V. Sharoyko, E. A. Popova, et al.
Russian Chemical Bulletin (2022) Vol. 71, Iss. 5, pp. 1050-1056
Closed Access | Times Cited: 8
Novel uracil derivatives as anti-cancer agents: Design, synthesis, biological evaluation and computational studies
Ladan Baziyar, Parinaz Ahmadi, Saman Zare Gheshlaghi, et al.
Journal of Molecular Structure (2023) Vol. 1302, pp. 137435-137435
Closed Access | Times Cited: 4
Synthesis and molecular docking studies of new aryl imeglimin derivatives as a potent antidiabetic agent in a diabetic zebrafish model
Aylin Khodakhah, Hassan Reza Mohammadi, Sina Abdoli, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Synthesis, spectroscopic characterization, crystal structure, DFT calculations, anti-cancer activities and Hirshfeld surface analysis of 2-((4-chlorophenyl)amino)-2-oxoethyl 2-ethylimidazo[1,2-a]pyridine-3-carboxylate
Yiding Geng, Yue Liu, Shuo Wang, et al.
Journal of Molecular Structure (2024) Vol. 1313, pp. 138701-138701
Closed Access | Times Cited: 1
Scalable Synthetic Strategy for Unsymmetrical Trisubstituted s-Triazines
Helong Liang, Ganzhong Li, Lei Zhang, et al.
Organic Letters (2021) Vol. 23, Iss. 15, pp. 5821-5825
Closed Access | Times Cited: 10
Mannich Reaction Involving 6-Amino-4-methyl-2-(thio)oxo-1,2-dihydropyridine-3,5-dicarbonitriles
A. O. Panaetov, В. Д. Стрелков, В. В. Доценко, et al.
Russian Journal of General Chemistry (2023) Vol. 93, Iss. 7, pp. 1655-1668
Closed Access | Times Cited: 3
Azole-methyl-3-(4-phenoxyphenyl) quinazolin-4(3H) ones, novel quinazoline-azole hybrid scaffolds, as new potent anticancer agents: Design, synthesis, biological evaluation, molecular dynamic simulation and theoretical approach
Saman Zare Gheshlaghi, Ali Ebrahimi, Zeinab Faghih, et al.
Tetrahedron (2023) Vol. 147, pp. 133650-133650
Closed Access | Times Cited: 3
A novel phospho triazine compound serving as an anticancer and antibacterial agent: An experimental-computational investigation
Khodayar Gholivand, Mohammad Hossein Hosseini Koupaei, Fahimeh Mohammadpanah, et al.
Journal of Molecular Structure (2022) Vol. 1263, pp. 133024-133024
Closed Access | Times Cited: 5
Hybrid PABA‐glutamic acid conjugated 1,3,5‐triazine derivatives: Design, synthesis, and antimalarial activity screening targeting Plasmodium falciparum dihydro folate reductase enzyme
Ayesha Aktar Khanam Choudhury, Sathishkumar Vinayagam, Nayana Adhikari, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 6, pp. 1336-1352
Closed Access | Times Cited: 2
Design, Synthesis, and Biological Evaluation of Tetrahydro‐α‐carbolines as Akt1 Inhibitors That Inhibit Colorectal Cancer Cell Proliferation
Li Guo, Xiang‐Hong He, Heping Li, et al.
ChemMedChem (2022) Vol. 17, Iss. 11
Closed Access | Times Cited: 4
Photo‐Clickable Triazine‐Trione Thermosets as Promising 3D Scaffolds for Tissue Engineering Applications
Å. Johansen, Jinjian Lin, Shuntaro Yamada, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 27
Open Access
Synthesis and bioassay of 3-Aryl -1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]- triazin-4(3H)-ones as anti-cancer agents
Bassam Abu Thaher, Ihab M. Almasri, Kanan Wahedy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 8, pp. 1797-1810
Closed Access | Times Cited: 1
SYNTHESIS OF NEW HYBRID MOLECULES WITH 1,3,5-TRIAZINE AND HYDROQUINOLINE MOIETIES
Do Van Quy, Phung Thi Chinh, Nadezhda V. Stolpovskaya, et al.
IZVESTIYA VYSSHIKH UCHEBNYKH ZAVEDENIY KHIMIYA KHIMICHESKAYA TEKHNOLOGIYA (2023) Vol. 66, Iss. 4, pp. 17-26
Open Access | Times Cited: 1
A concise review on anti-breast cancer effectiveness of s-triazines through EGFR kinase inhibition
P. K. Tandel, Rachana Upadhyay, Amit B. Patel
Medicinal Chemistry Research (2023)
Closed Access | Times Cited: 1
Structural characterization, analysis of hindered rotation and cytotoxic activity of N2,N4,N6-triphenethyl-1,3,5-triazine-2,4,6-triamine
Igor Resendes Barbosa, Catarina de Nigris Del Cistia, Vitor Almeida, et al.
Spectroscopy Letters (2021) Vol. 54, Iss. 8, pp. 607-618
Closed Access | Times Cited: 2
Diverse Synthetic Approaches and Biological Activities of Lucrative Pyrimidine- Triazine Hybrid Derivatives: A Review
Kalyani D. Asgaonkar, Shital Patil, Kunal Pradhan, et al.
Current Organic Synthesis (2022) Vol. 20, Iss. 7, pp. 734-757
Closed Access | Times Cited: 1
Recent advances in the synthetic thymidine phosphorylase inhibitors for cancer therapy
Qianqian Feng, Wei Yang, Zhiyun Peng, et al.
European Journal of Pharmacology (2022) Vol. 934, pp. 175319-175319
Closed Access | Times Cited: 1
Mannich reaction involving 6-amino-4-methyl2-(thio)oxo-1,2-dihydropyridine-3,5-dicarbonitriles
A. O. Panaetov, В. Д. Стрелков, В. В. Доценко, et al.
Журнал Общей Химии (2023) Vol. 93, Iss. 7, pp. 1007-1022
Closed Access
Page 1

Scroll to top